DayTwo

📍 Brentwood, United States🗓 Founded 2015👥 64 employees💰 Last funded Apr 2023
DayTwo offers a sustainable path to remission for metabolic disease (diabetes, prediabetes, clinical obesity, non-alcoholic fatty liver disease) that uses gut microbiome sequencing, artificial intelligence, and virtual care. After 10 years of scientific research, and the development of an AI-based algorithm that predicts blood sugar response to food, DayTwo’s virtual care solution reduces or eliminates medications by improving Time in Range and lowering A1C.
6
Total investors
1
Early stage
4
Mid stage
1
Late stage
2015
Founded
Investor geography4 countries
Israel
2
United States
2
Switzerland
1
United Kingdom
1
Investor activity2017–2023 · investors recorded per year
201712019420231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in DayTwo?
DayTwo has 6 investors on record on gritt.io, including 1 early-stage backers, 4 mid-stage and 1 late-stage investors.
When did DayTwo last raise funding?
The most recent investment in DayTwo recorded on gritt.io was in April 2023.
When was DayTwo founded?
DayTwo was founded in 2015.
What industry is DayTwo in?
DayTwo operates in Health and Human Services. Find similar Health and Human Services investors on gritt.io.
Where is DayTwo based?
DayTwo is headquartered in Brentwood, United States.